Reprint
Advances in the Treatment of Renal Cell Carcinoma
Edited by
February 2022
221 pages
- ISBN978-3-0365-2935-6 (Hardback)
- ISBN978-3-0365-2934-9 (PDF)
This book is a reprint of the Special Issue Advances in the Treatment of Renal Cell Carcinoma that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
renal cell carcinoma; autophagy; hydroxychloroquine; chloroquine; ROC-325; cysteine cathepsins; cysteine cathepsin inhibitors; lysosome; renal cancer; metastatic renal cell carcinoma; immune-based combination therapies; network meta-analysis; renal cell carcinoma; PD-L1; predictive; biomarker; treatment; TKIs; mRCC; biomarkers; soluble factors; biomarkers; immunotherapy; renal cell carcinoma; PD-L1; renal cell carcinoma (RCC); sunitib resistance; artesunate (ART); Traditional Chinese Medicine (TCM); growth inhibition; ferroptosis; reactive oxygen species (ROS); clear cell renal cell carcinoma; ccRCC; RCC; kidney cancer; evolution; evolutionary trajectory; biomarker; metastatic; renal cell carcinoma; second line therapy; renal cell cancer; immune checkpoint inhibitors; tyrosine kinase inhibitors; biomarkers; individualization; clear cell renal cell carcinoma; immune checkpoint inhibitors; biomarker; genomic signature; transcriptomic analysis